Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 136.67
-0.51 %
$ 21.7 B
Market Cap
-13.71
P/E
Price Target
Average
10.64%
Revenue Forecast
Estimate
5.86%
EBIT
Estimate
15.46%
Net Income
Estimate
42.81%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Illumina, Inc.
Wall Street analysts predict an average 1-year price target for ILMN of $151 , with forecasts ranging from
a
low of
$58 to a high of $200 .
ILMN Lowest Price Target
Wall Street Target
58 USD
-57.56%
ILMN Average Price Target
Wall Street Target
151 USD
10.64%
ILMN Highest Price Target
Wall Street Target
200 USD
46.34%
REVENUE FORECAST
Revenue Forecast Chart ILMN
EBIT FORECAST
EBIT Forecast Chart ILMN
NET INCOME FORECAST
Net Income Chart ILMN